An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

This chart shows the share of people diagnosed with tuberculosis (TB) who were cured/completed their treatment, by TB type (in %)*.

(Reuters) - The Food and Drug Administration has added Pfizer Inc's tuberculosis treatment rifampin to its list of drugs in short supply, the latest in a growing number of spottily available TB ...

Please provide your email address to receive an email when new articles are posted on . Three all-oral 9-month treatments for drug-resistant tuberculosis were found to be noninferior to standard ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

ATLANTA, Jan 17 (Reuters) - More than 80 percent of health departments in the United States that treat tuberculosis resistant to standard treatment have trouble obtaining the drugs they need to cure ...

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.